NASDAQ:SGMO
Sangamo Therapeutics, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.sangamo.comipo date
Apr 06, 2000
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in ...Show More
Earnings
Earnings Release in 10 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus